Document Detail


Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside.
MedLine Citation:
PMID:  15224375     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We present a case of a 21-year-old woman suffering from diffuse large B-cell lymphoma who developed acute anterior uveitis shortly after completing chemotherapeutic course with HYPER-CVAD protocol (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) alternating with methotrexate and high-dose cytosine-arabinoside (HIDAC), with poor adherence to recommended prophylactic treatment with saline eye drops. Complete resolution of her symptoms was achieved within a few days of treatment with topical steroids. To our knowledge this is the first report of acute anterior uveitis secondary to treatment with HIDAC. Differential diagnosis and a suggested mechanism are discussed.
Authors:
David Planer; Tali Cukierman; Diana Liebster; Michael Ilsar; Tova Chajek-Shaul
Related Documents :
9180405 - Latex elastic-induced periodontal damage: a case report on the subsequent orthodontic m...
19523275 - Erythroderma: a dermatologic emergency.
19582495 - Mirror foot: treatment of three cases and review of the literature.
9840375 - Malignant cerebellar astrocytomas in childhood. experience with four cases.
21172235 - Recurrent posterior scleritis and orbital myositis as extra-intestinal manifestations o...
3824095 - Postpartum sterilisation by the irving technique. a report of 200 cases at paarl hospit...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of hematology     Volume:  76     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-06-29     Completed Date:  2004-08-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  304-6     Citation Subset:  IM    
Copyright Information:
Copyright 2004 Wiley-Liss, Inc.
Affiliation:
Department of Medicine, Hadassah-Hebrew University Medical Center, Mount Scopus, PO Box 24035, Jerusalem 91240, Israel. dplaner@md.huji.ac.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Breast Neoplasms / drug therapy
Cytarabine / administration & dosage,  adverse effects*
Female
Humans
Lymphoma, B-Cell / drug therapy
Lymphoma, Large B-Cell, Diffuse / drug therapy
Uveitis, Anterior / chemically induced*,  drug therapy
Chemical
Reg. No./Substance:
147-94-4/Cytarabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, c...
Next Document:  Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell dise...